Allied Biomedical Research Institute (ABRI) is a global integrated biotechnology and clinical research company with headquarters in the United States and sites in South Florida, Santo Domingo, Guayaquil, Ciudad Bolivar, Maiquetilla, Puerto Ordaz, and Ahmedabad. ABRI is an independent and neutral source of bio-products, specializing in the collection of rare, highly characterized biological samples for clinical trial management solutions and its own inventory of bio-products. With certifications from NIH, CDC, and FDA, ABRI is highly qualified and excels in understanding the regulatory environment and project management capacities to expedite time to market for its customers.
ABRI offers a range of services, including phase 1 and phase II-IV clinical trials, where participants can contribute to important medical innovations in genetics, drugs, clinical techniques, and diagnostic tools. The state-of-the-art facilities at ABRI provide continuous medical monitoring and support for participants, ensuring safety and efficacy in the development of future medications. With a focus on science and lasting support to health, ABRI is dedicated to improving the lives of individuals through its research and biotechnology expertise.
Generated from the website